ArticleJournal of arrhythmia2018

Design and baseline characteristics of the Xarelto Post-Authorization Safety & Effectiveness Study in Japanese Patients with Atrial Fibrillation (XAPASS).

Satoshi Ogawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.